MedTrace Logo

Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients

NCT00627731 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-09-07

No results posted yet for this study

Summary

A comparison of oral prednisolone administration with intravenous methylprednisolone infusion in the treatment of acute asthma exacerbation in hospitalized patients. Oral glucocorticosteroids administration may be effective as intravenous high-dose methylprednisolone infusion.

Conditions

Interventions

DRUG

methylprednisolone sodium succinate (mPSL)

mPSL IV 240mg per day for 5 days and oral PSL 40mg per day for 5 days

DRUG

prednisolone (PSL)

PSL 40 mg per day for 10 days

Sponsors & Collaborators

  • Hamamatsu University

    lead OTHER

Principal Investigators

  • Kingo Chida, MD,PhD · Hamamatsu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627731 on ClinicalTrials.gov